Simplex Trading’s KALA BIO KALA Stock Holding History

Simplex Trading’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3	Closed	-$20K	–	9797
2022 Q3	$20K	Buy	3 +2	+200%	+$1.57K	﹤0.01%	7523
2022 Q2	$1K	Hold	1	–	–	﹤0.01%	9604
2022 Q1	$4K	Hold	1	–	–	﹤0.01%	9567
2021 Q4	$4K	Sell	1 -7	-88%	-$32.5K	﹤0.01%	9683
2021 Q3	$102K	Hold	8	–	–	﹤0.01%	6595
2021 Q2	$99K	Buy	+8	New	+$126K	﹤0.01%	6739
2021 Q1	–	Hold	0	–	–	–	3453
2020 Q4	–	Hold	0	–	–	–	2944
2020 Q3	–	Hold	0	–	–	–	4784
2020 Q2	–	Hold	0	–	–	–	3144
2020 Q1	–	Hold	0	–	–	–	2768
2019 Q4	–	Hold	0	–	–	–	5488
2019 Q3	–	Hold	0	–	–	–	6144
2019 Q2	–	Hold	0	–	–	–	5839
2019 Q1	–	Hold	0	–	–	–	6274
2018 Q4	–	Hold	0	–	-$14K	–	7397
2018 Q3	–	Hold	0	–	–	–	6226
2018 Q2	–	Hold	0	–	–	–	3495
2018 Q1	–	Hold	0	–	–	–	5663

Other funds holding KALA

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Simplex Trading's KALA Position: Q4 2022 in Review

Simplex Trading sold out of KALA BIO (KALA) in Q4 2022, closing a stake of 12 shares — an estimated $6K sold.

Simplex Trading first reported a position in KALA in Q3 2018 and held it in 12 quarters. The position peaked at $305K in Q4 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q4 2022.

Simplex Trading reported no remaining KALA BIO position as of Q4 2022 after selling out during the quarter.
Simplex Trading sold 12 KALA BIO shares in Q4 2022, an estimated $6K.
Simplex Trading first reported a position in KALA BIO in Q3 2018 and held it in 12 quarters.
Simplex Trading's KALA BIO position peaked at $305K in Q4 2020.
28 funds tracked by Wall St. Rank held KALA BIO as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.